Measuring the Influence of Side Effect Expectations, Beliefs, and Incident Side Effects on the Risk for Drug Discontinuation Among Individuals Starting New Medications, a Cross-sectional Study

References

• Virani SS, Alonso A, Aparicio HJ, et al. Heart disease and stroke statistics—2021 update. Circulation. 2021;143(8):e254–e743. doi:10.1161/CIR.0000000000000950
   PubMed Web of Science ®Google Scholar
• Herkert D, Vijayakumar P, Luo J, et al. Cost-related insulin underuse among patients with diabetes. JAMA Intern Med. 2019;179(1):112–114. doi:10.1001/jamainternmed.2018.5008
   PubMed Web of Science ®Google Scholar
• Mahtta D, Ramsey DJ, Al Rifai M, et al. Evaluation of aspirin and statin therapy use and adherence in patients with premature atherosclerotic cardiovascular disease. JAMA Network Open. 2020;3(8):e2011051–e2011051. doi:10.1001/jamanetworkopen.2020.11051
   PubMed Web of Science ®Google Scholar
• Navar AM, Roe MT, Cannon CP, et al. Medication discontinuation in the IMPROVE-IT trial. Circ Cardiovas Qual Outcomes. 2019;12:1–11.
   Web of Science ®Google Scholar
• Korhonen MJ, Robinson JG, Annis IE, et al. Adherence tradeoff to multiple preventive therapies and all-cause mortality after acute myocardial infarction. J Am Coll Cardiol. 2017;70(13):1543–1554. doi:10.1016/j.jacc.2017.07.783
   Web of Science ®Google Scholar
• Donnelly LA, Morris AD, Evans JM, Collaboration DM, Evans JMM. Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. Qjm. 2007;100(6):345–350. doi:10.1093/qjmed/hcm031
   PubMed Web of Science ®Google Scholar
• Krousel-Wood M, Joyce C, Holt E, et al. Predictors of decline in medication adherence. Results from the cohort study of medication adherence among older adults. Hypertension. 2011;58:804–810. doi:10.1161/HYPERTENSIONAHA.111.176859
   PubMed Web of Science ®Google Scholar
• Herttua K, Tabã¡k AG, Martikainen P, Vahtera J, Kivimã¤ki M. Adherence to antihypertensive therapy prior to the first presentation of stroke in hypertensive adults: population-based study. Eur Heart J. 2013;34:2933–2939. doi:10.1093/eurheartj/eht219
   PubMed Web of Science ®Google Scholar
• An J, Nichol MB. Multiple medication adherence and its effect on clinical outcomes among patients with comorbid type 2 diabetes and hypertension. Med Care. 2013;51:879–887. doi:10.1097/MLR.0b013e31829fa8ed
   PubMed Web of Science ®Google Scholar
• Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297(2):177–186. doi:10.1001/jama.297.2.177
   PubMed Web of Science ®Google Scholar
• Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch of Int Med. 2006;166(17):1836–1841. doi:10.1001/archinte.166.17.1836
   PubMed Web of Science ®Google Scholar
• Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44–47. doi:10.1111/j.1524-4733.2007.00213.x
   PubMed Web of Science ®Google Scholar
• Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705. doi:10.1111/j.1365-2125.2012.04167.x
   PubMed Web of Science ®Google Scholar
• Karter AJ, Parker MM, Moffet HH, Ahmed AT, Schmittdiel JA, Selby JV. New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. Health Serv Res. 2009;44(5):1640–1661. doi:10.1111/j.1475-6773.2009.00989.x
   Web of Science ®Google Scholar
• Evans CD, Eurich DT, Remillard AJ, Shevchuk YM, Blackburn DF. First-fill medication discontinuations and non-adherence to antihypertensive therapy: an observational study. Am J Hypertens. 2012;25:195–203. doi:10.1038/ajh.2011.198
   Web of Science ®Google Scholar
• Flory JH, Keating SJ, Siscovick D, Mushlin AI. Identifying prevalence and risk factors for metformin non-persistence: a retrospective cohort study using an electronic health record. BMJ open. 2018;8(7):e021505. doi:10.1136/bmjopen-2018-021505
   PubMed Web of Science ®Google Scholar
• Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14:1–24. doi:10.1080/08870449908407311
   Web of Science ®Google Scholar
• Alefan Q, Yao S, Taylor JG, et al. Factors associated with early nonpersistence among patients experiencing side effects from a new medication. J Am Pharm Assoc. 2022;62(3):717–726.e715. doi:10.1016/j.japh.2021.12.001
   Google Scholar
• Rief W, Avorn J, Barsky AJ. Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects. Arch Inter Med. 2006;166(2):155–160. doi:10.1001/archinte.166.2.155
   PubMed Web of Science ®Google Scholar
• MacKrill K, Webster R, Rubin GJ, et al. When symptoms become side effects: development of the side effect attribution scale (SEAS). J Psychosom Res. 2021;141:110340. doi:10.1016/j.jpsychores.2020.110340
   Web of Science ®Google Scholar
• Wood FA, Howard JP, Finegold JA, et al. N-of-1 trial of a statin, placebo, or no treatment to assess side effects. N Engl J Med. 2020;383(22):2182–2184. doi:10.1056/NEJMc2031173
   PubMed Web of Science ®Google Scholar
• Espinola CW, Khoo Y, Parmar R, et al. Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy. Brain Behavior. 2022;12(5):e2555. doi:10.1002/brb3.2555
   Web of Science ®Google Scholar
• Smith LE, Webster RK, Rubin GJ. A systematic review of factors associated with side-effect expectations from medical interventions. Health Expect. 2020;23(4):731–758. doi:10.1111/hex.13059
   Web of Science ®Google Scholar
• Dyck A, Deschamps M, Taylor J. Pharmacists’ discussions of medication side effects: a descriptive study. Patient Educ Couns. 2005;56(1):21–27. doi:10.1016/j.pec.2003.10.006
   Web of Science ®Google Scholar
• Dillman DA, Smyth JD, Christian LM. Internet, Mail, and Mixed-Mode: The Tailored Design Method. 3rd ed. Hoboken, NJ: John Wiley; 2009.
   Google Scholar
• McHorney CA. The adherence estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease. Curr Med Res Opin. 2009;25:215–238. doi:10.1185/03007990802619425
   PubMed Web of Science ®Google Scholar
• Bland JM, Altman DG. Cronbach’s alpha. BMJ. 1997;314(7080):572. doi:10.1136/bmj.314.7080.572
   PubMed Web of Science ®Google Scholar
• Pencina MJ, Steverberg EW, D’Agonstino RB. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30(1):11–21. doi:10.1002/sim.4085
   PubMed Web of Science ®Google Scholar
• Pencina MJ, D’Agonstino RB. Evaluating discrimination of risk prediction models. The C Statistic. JAMA. 2015;314(10):1063–1064. doi:10.1001/jama.2015.11082
   PubMed Web of Science ®Google Scholar
• Webster RK, Rubin GJ. Predicting expectations of side-effects for those which are warned versus not warned about in patient information leaflets. Ann Behav Med. 2021;55(12):1253–1261. doi:10.1093/abm/kaab015
   Web of Science ®Google Scholar
• Okuyan B, Sancar M, Izzettin FV. Assessment of medication knowledge and adherence among patients under oral chronic medication treatment in community pharmacy settings. Pharmacoepidemiol Drug Saf. 2013;22(2):209–214. doi:10.1002/pds.3275
   PubMed Web of Science ®Google Scholar
• Nair K, Dolovich L, Cassels A, et al. What patients want to know about their medications. Focus group study of patient and clinician perspectives. Cana Famil Phys Med Fame Canad. 2002;48:104–110.
   PubMed Web of Science ®Google Scholar
• Pound P, Britten N, Morgan M, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61(1):133–155. doi:10.1016/j.socscimed.2004.11.063
   PubMed Web of Science ®Google Scholar
• Kairuz T, Krehula D, Huynh T, Bellamy K. Exploring the process of conveying information about side effects: a qualitative study among pharmacists. Pharmacy. 2013;1(2):256–268. doi:10.3390/pharmacy1020256
   Google Scholar
• Salinas GD, Susalka D, Burton BS, et al. Risk assessment and counseling behaviors of healthcare professionals managing patients with chronic pain: a national multifaceted assessment of physicians, pharmacists, and their patients. J Opioid Manag. 2012;8(5):273–284. doi:10.5055/jom.2012.0127
   Google Scholar
• Martinson BC, Crain AL, Sherwood NE, Hayes MG, Pronk NP, O’Connor PJ. Population reach and recruitment bias in a maintenance RCT in physically active older adults. J Phys Act Health. 2010;7(1):127–135. doi:10.1123/jpah.7.1.127
   Web of Science ®Google Scholar
• Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47(6):555–567. doi:10.1016/S0022-3999(99)00057-4
   PubMed Web of Science ®Google Scholar